Of the nine patients with pre-treatment haemoglobin concentrations below 7 g/dL who were treated with tafenoquine, one returned on day 5 with acute haemolytic anaemia symptoms (G6PD normal). The gene discussed is G6PD; the disease is non-autoimmune hemolytic anemia.